Thrombopoietin (TPO)

346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine

Peter Attia MD

A drug Genentech hired Sue to work on, intended to increase platelet count, but proved difficult due to late and excessive platelet elevation.